Cerity Partners’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Sell
155,937
-23,404
-13% -$610K ﹤0.01% 1284
2026
Q1
$4.91M Buy
179,341
+57,819
+48% +$2.05M 0.01% 1022
2025
Q4
$5.05M Sell
121,522
-18,249
-13% -$740K 0.01% 917
2025
Q3
$6.45M Buy
139,771
+43,509
+45% +$2.32M 0.01% 761
2025
Q2
$5.09M Buy
96,262
+28,451
+42% +$1.5M 0.01% 793
2025
Q1
$3.77M Buy
+67,811
New +$3.25M 0.01% 841
2024
Q4
– Sell
-11,778
Closed -$604K – 2462
2024
Q3
$604K Buy
11,778
+5,663
+93% +$379K ﹤0.01% 1669
2024
Q2
$387K Sell
6,115
-429
-7% -$25.7K ﹤0.01% 1673
2024
Q1
$433K Buy
+6,544
New +$531K ﹤0.01% 1665

Other funds holding CNXC

Cerity Partners's CNXC Position: Q2 2026 in Review

Cerity Partners reduced its Concentrix (CNXC) stake by 13% in Q2 2026, selling an estimated $610K and leaving 155,937 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

Cerity Partners first reported a position in CNXC in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.45M in Q3 2025. 272 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Cerity Partners held 155,937 shares of Concentrix worth $3.49M as of Q2 2026.
  • Cerity Partners sold 23,404 Concentrix shares in Q2 2026, an estimated $610K.
  • Concentrix made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1284 holding.
  • Cerity Partners first reported a position in Concentrix in Q1 2024 and has held it in 9 quarters since.
  • Cerity Partners's Concentrix position peaked at $6.45M in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.